Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Michael Partridge - SVP of IR Reshma Kewalramani - CEO, President and Director Stuart Arbuckle - Executive VP and COO Charles Wagner - Executive VP and CFO Bastiano Sanna - Executive VP, Chief of Cell and Genetic Therapies and VCGT Site Head David Altshuler - Executive VP of Global Research and Chief Scientific Officer Conference Call Participants Cory Kasimov - JPMorgan Jason Zemansky - BofA Robyn Karnauskas - Truist Securities Salveen Richter - Goldman Sachs Michael Yee - Jefferies Phil Nadeau - Cowen & Company Colin Bristow - UBS Mohit Bansal - Wells Fargo Evan Seigerman - BMO Capital Markets Liisa Bayko - Evercore ISI Michael Partridge Good evening. This is Michael Partridge.